Performance-enhancing substance

Definition

The classifications of substances as performance-enhancing substances are not entirely clear-cut and objective. As in other types of categorization, certain prototype performance enhancers are universally classified as such (like anabolic steroids), whereas other substances (like vitamins and protein supplements) are virtually never classified as performance enhancers despite their effects on performance. As is usual with categorization, there are borderline cases; caffeine, for example, is considered a performance enhancer by some but not others.

Types

The phrase has been used to refer to several distinct classes of drugs:

Anabolic steroids

Main article: Anabolic steroid

Anabolic steroids are synthetically derived from testosterone and modified to have greater anabolic effects. They work by increasing the concentration of nitrogen in the muscle which inhibits catabolic glucocorticoid binding to muscle. This ultimately prohibits the breakdown of muscle and preserves muscle mass. Examples of anabolic steroids include: oxandrolone, stanozolol and nandrolone. Anabolic steroids can be taken through a transdermal method, orally, or through injection. Injectable forms of the steroid are the most potent and long-lasting. In general, potential side effects include: muscle hypertrophy, acne, hypertension, elevated cholesterol, thrombosis, decreased high-density lipoproteins, altered libido, hepatic carcinoma, cholestasis, peliosis hepatitis, septic arthritis, Wilm's tumor, psychosis, aggression, addiction, and depression. Potential side effects specifically in males include: male pattern baldness, oligospermia, prostate hypertrophy, testicular atrophy, and prostate cancer. Potential side specifically in females include: hirsutism, uterine atrophy, amenorrhea, breast atrophy, and thickening of vocal cords (voice deepening). Urine samples are tested to determine the ratio of testosterone glucuronide to epitestosterone glucuronide, which should be 3:1. Any ratio of 4:1 or greater is considered a positive test. The Anti-Drug Abuse Act of 1988 and the Anabolic Steroid Act of 1990 both deemed anabolic steroids as an illegal substance when not used for disease treatment.

Stimulants

Main article: Stimulant

Stimulants improve focus and alertness. Low (therapeutic) doses of dopaminergic stimulants (e.g., reuptake inhibitors and releasing agents) also promote mental and athletic performance, as cognitive enhancers and ergogenic aids respectively, by improving muscle strength and endurance while decreasing reaction time and fatigue. Stimulants are commonly used in lengthy exercises that require short bursts (e.g., tennis, team sports, etc.). Stimulants work by increasing catecholamine levels and agonistic activity at the adrenergic receptors. Examples of stimulants include caffeine, ephedrine, methylphenidate and amphetamine. Potential side effects include hypertension, insomnia, headaches, weight loss, arrhythmia, tremors, anxiety, addiction, and strokes. Some stimulants are allowed in competitive sports and are widely accessible, though may also be monitored by the World Anti-Doping Agency (WADA), such as caffeine. Others are banned as per the WADA (e.g., cocaine, amphetamines, ephedrine, etc.).

Ergogenic aids

Ergogenic aids, or athletic performance-enhancing substances, include a number of drugs with various effects on physical performance. Drugs such as amphetamine and methylphenidate increase power output at constant levels of perceived exertion and delay the onset of fatigue, among other athletic-performance-enhancing effects; bupropion also increases power output at constant levels of perceived exertion, but only during short-term use.

Examples

Main article: Human growth hormone, Creatine, Beta-Hydroxy-Beta-methylbutyrate

• Creatine: one of the most popular nutritional supplements, it contributes to 400 million dollars in sales globally every year. It is a nonessential amino acid that helps to improve an athlete's performance during short-term, high intensity exercises such as weightlifting. Supplementation of creatine increases skeletal muscle creatine levels, boosting performance by increasing the rate at which adenosine triphosphate can be replenished from adenosine diphosphate, thereby increasing maximal power output. Potential side effects include gastrointestinal cramps, weight gain, fatigue, and diarrhea. Creatine is currently not recognized as a prohibited substance and can be purchased as a legal dietary supplement.
• β-hydroxy β-methylbutyrate, a metabolite of leucine also used as a supplement, has positive effects on lean muscle mass, possibly through a decrease in muscle catabolism.
• Human Growth Hormone (hGH): endogenous hormone that can help decrease fat mass while increasing lean body mass. hGH is one of the most commonly used substances among professional athletes because it has a small window for detection. It works by promoting the release of IGF-1, insulin-like growth factor, the release of which has anabolic effects on the body. Potential side effects include: cardiomyopathy, diabetes, renal failure, and hepatitis. If not prescribed by a professional, it is a banned substance in competition per WADA. Despite its small window for detection, two primary methods of testing have been developed for hGH, one being an isoform test which detects changes in growth hormone structure in the blood, and the markers test, which detects changes in serum protein ratios.

Adaptogens

Main article: Adaptogen

Adaptogens are plants that support health through nonspecific effects, neutralize various environmental and physical stressors while being relatively safe and free of side effects. As of 2008, the position of the European Medicines Agency was that "The principle of an adaptogenic action needs further clarification and studies in the pre-clinical and clinical area. As such, the term is not accepted in pharmacological and clinical terminology that is commonly used in the EU."

Actoprotectors

Main article: Actoprotector

Actoprotectors or synthetic adaptogens are compounds that enhance an organism's resilience to physical stress without increasing heat output. Actoprotectors are distinct from other doping compounds in that they increase physical and psychological resilience via non-exhaustive action. Actoprotectors such as bemethyl and bromantane have been used to prepare athletes and enhance performance in Olympic competition. However, only bromantane has been placed on the World Anti-Doping Agency's banned list.

Nootropics

Main article: Nootropic

Nootropics, or "cognition enhancers", are substances that are claimed to benefit overall cognition by improving memory (e.g., increasing working memory capacity or updating) or other aspects of cognitive control (e.g., inhibitory control, attentional control, attention span, etc.).

CNS agents

Central nervous system agents are medicines that affect the central nervous system (CNS).

Painkillers

Main article: Analgesic

Allows performance beyond the usual pain threshold. Some painkillers raise blood pressure, increasing oxygen supply to muscle cells. Painkillers used by athletes range from common over-the-counter medicines which include NSAIDs (ibuprofen) to powerful prescription narcotics.

Sedatives and anxiolytics

Main article: Sedative, Anxiolytic

Sedatives and anxiolytics are used in sports like archery which require steady hands and accurate aim, and also to overcome excessive nervousness or discomfort for more dangerous sports. Diazepam, nicotine, and propranolol are common examples. Ethanol, the most commonly used substance by athletes, can be used for cardiovascular improvements though has significant detrimental effects. Ethanol was formerly banned by WADA during performance for athletes performing in aeronautics, archery, automobile, karate, motorcycling and powerboating, but was taken off the ban list in 2017. It is detected by breath or blood testing. Cannabis is banned at all times for an athlete by WADA, though performance-enhancing effects have yet to be studied. Cannabis and nicotine are detected through urine analysis.

Blood boosters

Main article: Blood doping

Blood doping agents increase the oxygen-carrying capacity of blood beyond the individual's natural capacity. They are used in endurance sports like long-distance running, cycling, and Nordic skiing. Recombinant human erythropoietin (rhEPO) is one of the most widely known drugs in this class. The Athlete Biological Passport is the only indirect testing method for detection of blood doping.

Erythropoietin

Main article: Erythropoietin

Erythropoietin, or EPO, is a hormone that helps increase the production of red blood cells which increases the delivery of oxygen to muscles. It is commonly used among endurance athletes such as cyclists. It functions by protecting red blood cells against destruction whilst simultaneously stimulating bone marrow cells to produce more red blood cells. Potential side effects include: dehydration and an increase in blood viscosity which could result in a pulmonary embolism or stroke. Per the WADA, it is a banned substance. Urine samples can be tested via electrophoresis, and blood samples via indirect markers.

Gene doping

Main article: Gene doping

Gene doping agents are a relatively recently described class of athletic performance-enhancing substances. These drug therapies, which involve viral vector-mediated gene transfer, are not known to currently be in use .

Prohormones

Main article: Prohormone

Also known as anabolic steroid precursors, they promote lean body mass. Once in the body, these precursors are converted to testosterone and increase endogenous testosterone. The desired effects of steroid precursors however, are often not seen as they do not bind well to androgen receptors. Examples of prohormones include norandrostendione, androstenediol, and dehydroepiandrosterone (DHEA). These steroids have little desired effect compared to anabolic steroids, but have the same side effects. Androstenedione in 2005 became classified as a controlled substance by WADA, however DHEA can still be obtained legally as an over-the-counter nutritional supplement.

History

While the use of PEDs has expanded in recent times, the practice of using substances to improve performance has been around since the Ancient Olympic Games. In the Olympic Games of 668 BC, Charmis had consumed a diet consisting of dried figs which was thought, at the time, to be a significant factor in winning the 200-yard stade race. Ancient Greek athletes at the time also incorporated substances such as wine and brandy into their training routines. Stimulants derived from plants (e.g., Cola nitida, Bufotein, etc.) were used by the Roman gladiators to overcome injuries and fatigue.

In the late 19th century as modern medicine and pharmacology were developing, PEDs saw an increase in use. Supplements were now exclusively being used to enhance muscular work capacity. The main substances being used included alcoholic drinks, caffeine, and mixtures created by the athletic trainers (e.g., strychnine tablets made of cocaine and brandy).

In the 20th century, testosterone was isolated and characterized by scientists. In 1941, the first record of synthesized testosterone use occurred when a horse was given testosterone which successfully improved its race performance. Sports trainers soon after began advocating for testosterone use. Images of bodybuilders with massive muscles began circulating which further perpetuated a desire among athletes to use testosterone. In 1967, the first prohibited substance list and anti-doping measures were implemented at the 1968 Olympics.

In the 1980s, the main PEDs were cortisone and anabolic steroids. The United States Congress established the Anti-Drug Abuse Act of 1988 to criminalize the distribution and possession of non-medical anabolic steroids. In 1999, WADA was formed to address the escalating use of substances in sports, particularly after the 1998 doping scandal in cycling.

Risk factors

Adolescents are the most vulnerable group when it comes to taking performance-enhancing substances. This is in part due to the significance placed on physical appearance by this age group as well as feelings of invincibility combined with a lack of knowledge surrounding long-term consequences. Studies have shown that the most common gendered risk factors include being an adolescent female dissatisfied with their body weight or an adolescent male who perceives larger body sizes as the ideal. Having a negative body image or a history of depression can also be a significant risk factor. These are further exacerbated by parental pressures surrounding appearance, media influence, and peer pressure.

Studies show that adolescent males who engage with fitness magazines are twice as likely to use performance-enhancing substances. Adolescents who partake in competitive sports are at a particularly high risk, with those involved in gridiron football, basketball, wrestling, baseball, and gymnastics at the top.

Usage in sport

Main article: Doping in sport

In sports, the term performance-enhancing drugs is popularly used in reference to anabolic steroids or their precursors (hence the colloquial term steroids); anti-doping organizations apply the term broadly. Agencies such as the WADA and United States Anti-Doping Agency try to prevent athletes from using these drugs by performing drug tests. When medical exemptions are granted they are called therapeutic use exemptions.

References

References

1. (May 2019). "Effects of Performance-Enhancing Drugs | USADA".
2. (December 2013). "The effects of caffeine, nicotine, ethanol, and tetrahydrocannabinol on exercise performance". Nutrition & Metabolism.
3. (June 2013). "Nutritional supplements and ergogenic AIDS". Primary Care.
4. (8 March 2004). "Better Fighting Through Chemistry? The Role of FDA Regulation in Crafting the Warrior of the Future".
5. "Caffeine and Sports Performance". Vanderbilt.edu.
6. Kicman, A T. (June 2008). "Pharmacology of anabolic steroids". British Journal of Pharmacology.
7. (2024). "StatPearls". StatPearls Publishing.
8. "Performance Enhancing Anabolic Steroid Abuse in Women".
9. (2014-08-14). "Drug abuse in athletes". Substance Abuse and Rehabilitation.
10. (June 2010). "Adverse health effects of anabolic–androgenic steroids". Regulatory Toxicology and Pharmacology.
11. (19 January 2021). "Adverse Effects of Anabolic-Androgenic Steroids: A Literature Review". Healthcare.
12. (2008). "The Sports Medicine Resource Manual".
13. (July 2011). "Attention-deficit hyperactivity disorder and the athlete: new advances and understanding". Clinics in Sports Medicine.
14. (October 2013). "Executive dysfunction in Parkinson's disease and timing deficits". Frontiers in Integrative Neuroscience.
15. "Office of Dietary Supplements – Dietary Supplements for Exercise and Athletic Performance".
16. (2022). "Stimulants". StatPearls Publishing.
17. (May 2013). "Neurophysiological determinants of theoretical concepts and mechanisms involved in pacing". Sports Medicine.
18. (March 2015). "Is it time to turn our attention toward central mechanisms for post-exertional recovery strategies and performance?". Frontiers in Physiology.
19. (May 2016). "Considerations in the Use of Stimulants in Sport". Sports Medicine (Auckland, N.Z.).
20. (January 2015). "Caffeine: Cognitive and Physical Performance Enhancer or Psychoactive Drug?". Current Neuropharmacology.
21. "The Prohibited List".
22. (June 2015). "Neurophysiological effects of exercise in the heat". Scandinavian Journal of Medicine & Science in Sports.
23. (2017-10-23). "Creatine Use in Sports". Sports Health.
24. Kreider, Richard B.. (February 2003). "Effects of creatine supplementation on performance and training adaptations". Molecular and Cellular Biochemistry.
25. (December 2006). "Side effects of creatine supplementation in athletes". International Journal of Sports Physiology and Performance.
26. Perishable. (2021-03-10). "What Do Athletes Need to Know About Creatine? {{!}} USADA".
27. (April 2015). "Performance-enhancing substances in sports: a review of the literature". Sports Medicine.
28. (July 2006). "Human growth hormone doping in sport". British Journal of Sports Medicine.
29. Laron, Z. (October 2001). "Insulin-like growth factor 1 (IGF-1): a growth hormone". Molecular Pathology.
30. (October 2018). "The Use and Abuse of Human Growth Hormone in Sports". Sports Health.
31. Baumann, Gerhard P.. (April 2012). "Growth hormone doping in sports: a critical review of use and detection strategies". Endocrine Reviews.
32. (August 2013). "New insights into dietary supplements used in sport: active substances, pharmacological and side effects". Current Drug Targets.
33. (8 May 2008). "Reflection Paper on the Adaptogenic Concept". European Medicines Agency Committee on Herbal Medicinal Products.
34. (September 2012). "The pharmacology of actoprotectors: practical application for improvement of mental and physical performance". Biomolecules & Therapeutics.
35. (1997-09-27). "Bromontan, a new doping agent". Lancet.
36. (January 2015). "Smart drugs and synthetic androgens for cognitive and physical enhancement: revolving doors of cosmetic neurology". Current Neuropharmacology.
37. (June 2015). "Prescription Stimulants' Effects on Healthy Inhibitory Control, Working Memory, and Episodic Memory: A Meta-analysis". Journal of Cognitive Neuroscience.
38. (5 October 2017). ""No need for laboratory to test for alcohol" – WADA". www.insidethegames.biz.
39. Mairbäurl, Heimo. (2013-11-12). "Red blood cells in sports: effects of exercise and training on oxygen supply by red blood cells". Frontiers in Physiology.
40. (2020-09-18). "Erythropoietin regulation of red blood cell production: from bench to bedside and back". F1000Research.
41. (2018-03-15). "Erythropoietin as a performance-enhancing drug: Its mechanistic basis, detection, and potential adverse effects". Molecular and Cellular Endocrinology.
42. (November 2012). "Detection of EPO doping and blood doping: the haematological module of the Athlete Biological Passport". Drug Testing and Analysis.
43. (May 2020). "Genetics and the Elite Athlete: Our Understanding in 2020". Indian Journal of Orthopaedics.
44. (December 2002). "Prohormones and sport". The Journal of Steroid Biochemistry and Molecular Biology.
45. (July 2006). "Dehydroepiandrosterone (DHEA) is an anabolic steroid like dihydrotestosterone (DHT), the most potent natural androgen, and tetrahydrogestrinone (THG)". The Journal of Steroid Biochemistry and Molecular Biology.
46. Broeder, Craig E.. (February 2003). "Oral andro-related prohormone supplementation: do the potential risks outweigh the benefits?". Canadian Journal of Applied Physiology.
47. (August 2006). "Testosterone prohormone supplements". Medicine and Science in Sports and Exercise.
48. (March 2003). "The toxic torch of the modern Olympic Games". Veterinary and Human Toxicology.
49. (August 2009). "The history of doping and growth hormone abuse in sport". Growth Hormone & IGF Research.
50. (2022-12-26). "Contemporary blood doping—Performance, mechanism, and detection". Scandinavian Journal of Medicine & Science in Sports.
51. (2010). "Doping in sports in ancient and recent times". Medicina Nei Secoli.
52. (June 2007). "Doping in sports and its spread to at-risk populations: an international review". World Psychiatry.
53. (2018). "Physiology and Pathophysiology in Ultra-Marathon Running". Frontiers in Physiology.
54. (February 2001). "A brief history of testosterone". The Journal of Urology.
55. (12 October 2016). "A review of designer anabolic steroids in equine sports: Designer steroids in equine sports". Drug Testing and Analysis.
56. (June 1946). "Testosterone pellet implantation". The Journal of Clinical Endocrinology and Metabolism.
57. National Institute on Drug Abuse. "What is the history of anabolic steroid use?".
58. (July 2021). "Implanted Port Catheter System Infection Caused by Methicillin-resistant Staphylococcus pseudintermedius ST71-SCCmec type III". Internal Medicine.
59. (March 2017). "Performance-Enhancing Drug Use in Adolescence". American Journal of Lifestyle Medicine.
60. (June 2012). "Performance-enhancing drugs". Pediatrics in Review.
61. (March 2014). "Relationships between body image, nutritional supplement use, and attitudes towards doping in sport among adolescent boys: implications for prevention programs". Journal of the International Society of Sports Nutrition.
62. "Performance-Enhancing Drug Resources". Drug Free Sport.
63. (14 November 2013). "Who we are".
64. "U.S. Anti-Doping Agency – USADA".